[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Chromosomal Abnormality Market Report 2016

September 2016 | 115 pages | ID: UC57A929A1AEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Chromosomal Abnormality

Revenue, means the sales value of Chromosomal Abnormality

This report studies sales (consumption) of Chromosomal Abnormality in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Abbott Molecular Inc. (US)
  • Life Technologies Corporation (US)
  • Affymetrix, Inc. (US)
  • PerkinElmer, Inc. (US)
  • Bluegnome, ltd. (UK)
  • Applied Spectral Imaging (US)
  • SciGene Corporation (US)
  • BI Biological Industries (Israel)
  • ChromTrax (US)
  • CytoTest, Inc. (UK)
  • Cytognomix, Inc. (Canada)
  • Illumina, Inc. (US)
  • Inter Medico (Canada)
  • Kreatech Diagnostics (The Netherlands)
  • Oxford Gene Technology (UK)
  • Roche NimbleGen, Inc. (US)
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Chromosomal Abnormality in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
United States Chromosomal Abnormality Market Report 2016

1 CHROMOSOMAL ABNORMALITY OVERVIEW

1.1 Product Overview and Scope of Chromosomal Abnormality
1.2 Classification of Chromosomal Abnormality
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Chromosomal Abnormality
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Chromosomal Abnormality (2011-2021)
  1.4.1 United States Chromosomal Abnormality Sales and Growth Rate (2011-2021)
  1.4.2 United States Chromosomal Abnormality Revenue and Growth Rate (2011-2021)

2 UNITED STATES CHROMOSOMAL ABNORMALITY COMPETITION BY MANUFACTURERS

2.1 United States Chromosomal Abnormality Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Chromosomal Abnormality Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Chromosomal Abnormality Average Price by Manufactures (2015 and 2016)
2.4 Chromosomal Abnormality Market Competitive Situation and Trends
  2.4.1 Chromosomal Abnormality Market Concentration Rate
  2.4.2 Chromosomal Abnormality Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CHROMOSOMAL ABNORMALITY SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Chromosomal Abnormality Sales and Market Share by Type (2011-2016)
3.2 United States Chromosomal Abnormality Revenue and Market Share by Type (2011-2016)
3.3 United States Chromosomal Abnormality Price by Type (2011-2016)
3.4 United States Chromosomal Abnormality Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CHROMOSOMAL ABNORMALITY SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Chromosomal Abnormality Sales and Market Share by Application (2011-2016)
4.2 United States Chromosomal Abnormality Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CHROMOSOMAL ABNORMALITY MANUFACTURERS PROFILES/ANALYSIS

5.1 Abbott Molecular Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Chromosomal Abnormality Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Abbott Molecular Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Life Technologies Corporation (US)
  5.2.2 Chromosomal Abnormality Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Life Technologies Corporation (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Affymetrix, Inc. (US)
  5.3.2 Chromosomal Abnormality Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Affymetrix, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 PerkinElmer, Inc. (US)
  5.4.2 Chromosomal Abnormality Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 PerkinElmer, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Bluegnome, ltd. (UK)
  5.5.2 Chromosomal Abnormality Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Bluegnome, ltd. (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Applied Spectral Imaging (US)
  5.6.2 Chromosomal Abnormality Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Applied Spectral Imaging (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 SciGene Corporation (US)
  5.7.2 Chromosomal Abnormality Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 SciGene Corporation (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 BI Biological Industries (Israel)
  5.8.2 Chromosomal Abnormality Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 BI Biological Industries (Israel) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 ChromTrax (US)
  5.9.2 Chromosomal Abnormality Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 ChromTrax (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 CytoTest, Inc. (UK)
  5.10.2 Chromosomal Abnormality Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 CytoTest, Inc. (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Cytognomix, Inc. (Canada)
5.12 Illumina, Inc. (US)
5.13 Inter Medico (Canada)
5.14 Kreatech Diagnostics (The Netherlands)
5.15 Oxford Gene Technology (UK)
5.16 Roche NimbleGen, Inc. (US)

6 CHROMOSOMAL ABNORMALITY MANUFACTURING COST ANALYSIS

6.1 Chromosomal Abnormality Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Chromosomal Abnormality

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Chromosomal Abnormality Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Chromosomal Abnormality Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CHROMOSOMAL ABNORMALITY MARKET FORECAST (2016-2021)

10.1 United States Chromosomal Abnormality Sales, Revenue Forecast (2016-2021)
10.2 United States Chromosomal Abnormality Sales Forecast by Type (2016-2021)
10.3 United States Chromosomal Abnormality Sales Forecast by Application (2016-2021)
10.4 Chromosomal Abnormality Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Chromosomal Abnormality
Table Classification of Chromosomal Abnormality
Figure United States Sales Market Share of Chromosomal Abnormality by Type in 2015
Table Application of Chromosomal Abnormality
Figure United States Sales Market Share of Chromosomal Abnormality by Application in 2015
Figure United States Chromosomal Abnormality Sales and Growth Rate (2011-2021)
Figure United States Chromosomal Abnormality Revenue and Growth Rate (2011-2021)
Table United States Chromosomal Abnormality Sales of Key Manufacturers (2015 and 2016)
Table United States Chromosomal Abnormality Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Chromosomal Abnormality Sales Share by Manufacturers
Figure 2016 Chromosomal Abnormality Sales Share by Manufacturers
Table United States Chromosomal Abnormality Revenue by Manufacturers (2015 and 2016)
Table United States Chromosomal Abnormality Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Chromosomal Abnormality Revenue Share by Manufacturers
Table 2016 United States Chromosomal Abnormality Revenue Share by Manufacturers
Table United States Market Chromosomal Abnormality Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Chromosomal Abnormality Average Price of Key Manufacturers in 2015
Figure Chromosomal Abnormality Market Share of Top 3 Manufacturers
Figure Chromosomal Abnormality Market Share of Top 5 Manufacturers
Table United States Chromosomal Abnormality Sales by Type (2011-2016)
Table United States Chromosomal Abnormality Sales Share by Type (2011-2016)
Figure United States Chromosomal Abnormality Sales Market Share by Type in 2015
Table United States Chromosomal Abnormality Revenue and Market Share by Type (2011-2016)
Table United States Chromosomal Abnormality Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Chromosomal Abnormality by Type (2011-2016)
Table United States Chromosomal Abnormality Price by Type (2011-2016)
Figure United States Chromosomal Abnormality Sales Growth Rate by Type (2011-2016)
Table United States Chromosomal Abnormality Sales by Application (2011-2016)
Table United States Chromosomal Abnormality Sales Market Share by Application (2011-2016)
Figure United States Chromosomal Abnormality Sales Market Share by Application in 2015
Table United States Chromosomal Abnormality Sales Growth Rate by Application (2011-2016)
Figure United States Chromosomal Abnormality Sales Growth Rate by Application (2011-2016)
Table Abbott Molecular Inc. (US) Basic Information List
Table Abbott Molecular Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Molecular Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Life Technologies Corporation (US) Basic Information List
Table Life Technologies Corporation (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Life Technologies Corporation (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Affymetrix, Inc. (US) Basic Information List
Table Affymetrix, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Affymetrix, Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table PerkinElmer, Inc. (US) Basic Information List
Table PerkinElmer, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table PerkinElmer, Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Bluegnome, ltd. (UK) Basic Information List
Table Bluegnome, ltd. (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bluegnome, ltd. (UK) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Applied Spectral Imaging (US) Basic Information List
Table Applied Spectral Imaging (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Applied Spectral Imaging (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table SciGene Corporation (US) Basic Information List
Table SciGene Corporation (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table SciGene Corporation (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table BI Biological Industries (Israel) Basic Information List
Table BI Biological Industries (Israel) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table BI Biological Industries (Israel) Chromosomal Abnormality Sales Market Share (2011-2016)
Table ChromTrax (US) Basic Information List
Table ChromTrax (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table ChromTrax (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table CytoTest, Inc. (UK) Basic Information List
Table CytoTest, Inc. (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table CytoTest, Inc. (UK) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Cytognomix, Inc. (Canada) Basic Information List
Table Cytognomix, Inc. (Canada) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cytognomix, Inc. (Canada) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Illumina, Inc. (US) Basic Information List
Table Illumina, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Inter Medico (Canada) Basic Information List
Table Inter Medico (Canada) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Inter Medico (Canada) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Kreatech Diagnostics (The Netherlands) Basic Information List
Table Kreatech Diagnostics (The Netherlands) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kreatech Diagnostics (The Netherlands) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Oxford Gene Technology (UK) Basic Information List
Table Oxford Gene Technology (UK) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oxford Gene Technology (UK) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Roche NimbleGen, Inc. (US) Basic Information List
Table Roche NimbleGen, Inc. (US) Chromosomal Abnormality Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche NimbleGen, Inc. (US) Chromosomal Abnormality Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chromosomal Abnormality
Figure Manufacturing Process Analysis of Chromosomal Abnormality
Figure Chromosomal Abnormality Industrial Chain Analysis
Table Raw Materials Sources of Chromosomal Abnormality Major Manufacturers in 2015
Table Major Buyers of Chromosomal Abnormality
Table Distributors/Traders List
Figure United States Chromosomal Abnormality Production and Growth Rate Forecast (2016-2021)
Figure United States Chromosomal Abnormality Revenue and Growth Rate Forecast (2016-2021)
Table United States Chromosomal Abnormality Production Forecast by Type (2016-2021)
Table United States Chromosomal Abnormality Consumption Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories